Literature DB >> 22458302

The evolution of orgasmic pain (dysorgasmia) following radical prostatectomy.

Kazuhito Matsushita1, Raanan Tal, John P Mulhall.   

Abstract

INTRODUCTION: It is recognized that some patients experience painful orgasms known as dysorgasmia after radical prostatectomy (RP). This problem poses a barrier to satisfactory sexual relations for some couples. However, the natural history of this condition remains unknown. AIM: To assess the evolution of dysorgasmia in patients who underwent RP.
METHODS: The study population included men who had been seen initially within 6 months after RP and complained of postoperative dysorgasmia and opted for no medical therapy with postoperative follow-up at least 24 months, and were seen at least twice over 2 years. MAIN OUTCOME MEASURES: A proprietary dysorgasmia frequency scale and visual analog scale (VAS) for pain were used at each visit.
RESULTS: Data from 702 patients who had RP and presented for sexual function evaluation between 2002 and 2008 were prospectively collected and analyzed at Memorial Sloan-Kettering Cancer Center. Of the 702 patients, 84 (12%) complained of dysorgasmia. Mean patient age was 64 ± 16 years. Mean time interval since RP to initial sexual medicine interview was 2.2 ± 3.2 months. Mean number of visits was 4 ± 1.4. For the 84 patients who had dysorgasmia, mean dysorgasmia frequency and VAS score for pain at initial interview were 3.9 and 4.1, respectively. At 24 months, a statistically significant decrease in symptoms occurred, with 72%, 26%, and 7% of patients still complaining of pain at 12, 18, and 24 months, respectively. At 6 months, 26% of patients had a VAS score ≥6/10 and at 24 months this figure was 16%.
CONCLUSIONS: Our data provide evidence that dysorgasmia decreases in frequency and degree over time after RP. These data are in support of a surveillance strategy for all but the most bothered patients with dysorgasmia after RP.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22458302     DOI: 10.1111/j.1743-6109.2012.02699.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  8 in total

Review 1.  Focusing on sexual rehabilitation besides penile rehabilitation following radical prostatectomy is important.

Authors:  Daphné Vanderhaeghe; Maarten Albersen; Emmanuel Weyne
Journal:  Int J Impot Res       Date:  2021-03-22       Impact factor: 2.896

Review 2.  Psychosocial perspectives on sexual recovery after prostate cancer treatment.

Authors:  Lauren M Walker; Richard J Wassersug; John W Robinson
Journal:  Nat Rev Urol       Date:  2015-03-10       Impact factor: 14.432

Review 3.  Neglected side effects to curative prostate cancer treatments.

Authors:  Alexander B Nolsøe; Christian Fuglesang S Jensen; Peter B Østergren; Mikkel Fode
Journal:  Int J Impot Res       Date:  2020-12-14       Impact factor: 2.896

Review 4.  Orgasmic Dysfunction after Radical Prostatectomy.

Authors:  Paolo Capogrosso; Eugenio Ventimiglia; Walter Cazzaniga; Francesco Montorsi; Andrea Salonia
Journal:  World J Mens Health       Date:  2017-04       Impact factor: 5.400

Review 5.  Painful Ejaculation - An Ignored Symptom.

Authors:  Muhammad Waqar; Kawa Omar; Amr Moubasher; Oliver Brunckhorst; Kamran Ahmed
Journal:  Cureus       Date:  2020-10-30

Review 6.  Mapping the prevalence and use of questionnaires to detect the neglected sexual side effects after prostate cancer treatment: a scoping review.

Authors:  Pierre Röscher; Ronisha Sathiram; Joanne E Milios; Jacqueline M van Wyk
Journal:  Syst Rev       Date:  2022-01-03

Review 7.  Retrograde ejaculation, painful ejaculation and hematospermia.

Authors:  Arie Parnham; Ege Can Serefoglu
Journal:  Transl Androl Urol       Date:  2016-08

8.  Scandinavian Prostate Cancer Patients' Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment.

Authors:  Gert Martin Hald; Mie Dahl Pind; Michael Borre; Theis Lange
Journal:  Sex Med       Date:  2018-07-13       Impact factor: 2.491

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.